Lupin Pharma Ka Big Move! Philippines Mein Stake Badhaya, **$39.6M** Ki Deal Ki Announcement!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Lupin Pharma Ka Big Move! Philippines Mein Stake Badhaya, **$39.6M** Ki Deal Ki Announcement!
Overview

Lupin Pharma ne Philippines market mein apni position aur pakki karne ka faisla kiya hai. Unki Dutch subsidiary, Nanomi B.V., ab Multicare Pharmaceuticals Philippines (MPPI) ka **43.38%** additional stake kareeb **$39.6 million** mein buy karegi. Yeh deal unke market presence ko boost karegi aur operations ko integrate karne mein help karegi.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Philippines Mein Paisa Lagane Ka Plan!

Lupin Pharma apni reach ko Philippines mein aur badha raha hai. Iske liye, unki poori tarah se owned Dutch subsidiary Nanomi B.V., Multicare Pharmaceuticals Philippines, Inc. (MPPI) ke 11,794,497 shares kharid rahi hai. Yeh shares MPPI ke 43.38% stake ke barabar hain.

Yeh Acquisition Kyun Kar Rahe Hain?

Is move ka goal hai Lupin ka market mein foothold mazboot karna aur MPPI ke operations ko aur smoothly integrate karna. Yaad rahe, Nanomi B.V. pehle se hi MPPI mein 56.28% stake rakhti hai. Ab is nayi kharidari ke baad, Lupin ka MPPI mein total ownership lagbhag 100% ho jayega, jisse company ko future ke liye bade strategic decisions lene mein poori flexibility milegi aur long-term value bhi generate hogi. MPPI Philippines mein pharma products aur medical devices ki trading, importing, marketing, aur distribution ka kaam sambhalti hai.

Deal Ki Details Aur Kab Tak Hogi Poori?

Yeh poori deal cash mein hogi aur iski total value $39.6 million tak ja sakti hai. Lupin ne bataya hai ki yeh related party transaction hai aur audit committee se isko approval mil gayi hai. Promoters ya unke groups ka isme koi direct interest nahi hai. Transaction fair market value par ho, iske liye Ernst & Young Merchant Banking Services LLP ne valuation report bhi di hai.

Deal ko May 2026 ke end tak complete karne ka target rakha gaya hai, jab sasuri conditions poori ho jayengi. Yeh step Lupin ke international business ko grow karne aur important emerging markets mein apni share badhane ke commitment ko show karta hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.